Regenerative protocol for lupus management using umbilical cord mesenchymal stem cells as core therapy, integrated with physical therapy and nutritional medicine. Minimally invasive techniques.
Clinical Rationale
Umbilical cord mesenchymal stem cells exert immunomodulatory effects by regulating T-cell responses, reducing pro-inflammatory cytokines (TNF-α, IL-17), and promoting regulatory T-cell expansion. This may help rebalance the immune system and reduce autoimmune activity. The protocol is strictly adjunctive; current rheumatologic management remains essential. Physical therapy focuses on maintaining joint function, pain management, and fatigue reduction. Nutritional medicine targets inflammation control, oxidative stress modulation, and immune support. All techniques are minimally invasive (intravenous infusion). Peer‑reviewed investigations focus on safety and preliminary efficacy.